Science Alliance - A Schering-Plough Life Science Initiative

Offering partnership in the development of new treatments

As Schering-Plough aims to deliver a steady flow of innovative, science-based medicines and services to our customers, we value innovation and ground-breaking science whether it is developed internally or in-licensed.

Schering-Plough recognises that while the biotechnology industry in Australia is still relatively young, the science is world-class  producing what are potentially noveltherapeutic candidates. access to capital and help with strategic direction are two of the reasons biotech companies and universities look to partner with us.

At the same time, there is a growing need for companies such as Schering-Plough to identify and commercialise cutting edge research outside the company’s own pipeline. Competition for external research partnerships is intense.

To this end, the Science Alliance initiative plays a vital role as we work collaboratively to identify potential products, projects or partnerships that may become tomorrow’s medicines. We aim to facilitate the advancement and commercialisation of Australian medical research and innovation by identifying funding pathways for development and creating partnerships with centres of medical research excellence.

Having operated in Australia for over fifty years, Schering-Plough is uniquely positioned to take a leadership role in Australian partnerships with the life sciences industry. With a broad therapeutic interest, the company is a credible partner and collaborator.

More information on the criteria for partnership, the submission process and who is involved in the Science Alliance is available in our Science Alliance brochure (pdf, 489KB).

To discuss partnerships with Schering Plough, please contact Dr Edward Watson.